SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/EA18857DED8C0B2E85B7EA6D3A9AC5807CDE308604FD95E9CF95237CB3BD4F22C8B69264AB9B098AE5C39C1F78DED722>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/EA18857DED8C0B2E85B7EA6D3A9AC5807CDE308604FD95E9CF95237CB3BD4F22C8B69264AB9B098AE5C39C1F78DED722
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/EA18857DED8C0B2E85B7EA6D3A9AC5807CDE308604FD95E9CF95237CB3BD4F22C8B69264AB9B098AE5C39C1F78DED722
http://www.w3.org/2000/01/rdf-schema#comment
"Data show that At early stages tumors demonstrated reduced MHC class I expression and increased expression of natural killer group 2D ligands (NKG2D-L)."
xsd:string
http://purl.uniprot.org/uniprot/#_28A55D494B465542F0B15C5FFC1476FF43DBEC47866285A43455065CC482CFEB49FB07F3206F55442B7E2E580A74B6C9
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/EA18857DED8C0B2E85B7EA6D3A9AC5807CDE308604FD95E9CF95237CB3BD4F22C8B69264AB9B098AE5C39C1F78DED722
http://purl.uniprot.org/uniprot/O19453
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/EA18857DED8C0B2E85B7EA6D3A9AC5807CDE308604FD95E9CF95237CB3BD4F22C8B69264AB9B098AE5C39C1F78DED722
http://purl.uniprot.org/uniprot/#_O19453-mappedCitation-19950185
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/EA18857DED8C0B2E85B7EA6D3A9AC5807CDE308604FD95E9CF95237CB3BD4F22C8B69264AB9B098AE5C39C1F78DED722